Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: A multicentre prospective study of 1000 patients

Annals of the Rheumatic Diseases

Volumn 68, Issue 9, 2009, Pages 1428-1432

  Cervera, R ^a   Khamashta, M A ^b   Shoenfeld, Y ^c   Camps, M T ^d   Jacobsen, S ^e   Kiss, E ^f   Zeher, M M ^f   Tincani, A ^g   Kontopoulou Griva, I ^h   Galeazzi, M ⁱ   Bellisai, F ⁱ   Meroni, P L ^j   Derksen, R H W M ^k   De Groot, P G ^k   Gromnica Ihle, E ^l   Baleva, M ^m   Mosca, M ⁿ   Bombardieri, S ⁿ   Houssiau, F ^o   Gris, J C ^p   Quere I ^p   Hachulla, E ^q   Vasconcelos, C ^r   Roch, B ^s   Fernandez Nebro A ^d   Piette, J C ^t   Espinosa, G ^a   Bucciarelli, S ^a   Pisoni, C N ^b   Bertolaccini, M L ^b   Boffa, M C ^t   Hughes, G R V ^b   more..

^a HOSPITAL CLÍNIC   (Spain)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c SHEBA MEDICAL CENTER   (Israel)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^e Mental Health Services CPH   (Denmark)

^f UNIVERSITY OF DEBRECEN   (Hungary)

^g SPEDALI CIVILI   (Italy)

^h HIPPOKRATION HOSPITAL   (Greece)

ⁱ UNIVERSITY HOSPITAL OF SIENA   (Italy)

^j UNIVERSITY OF MILAN   (Italy)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l MARTIN LUTHER KRANKENHAUS   (Germany)

^m MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

ⁿ UNIVERSITY OF PISA   (Italy)

^o CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^p NÎMES UNIVERSITY HOSPITAL   (France)

^q LILLE UNIVERSITY HOSPITAL   (France)

^r HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^s UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^t PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL BLEEDING; ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BACTERIAL INFECTION; BRAIN HEMORRHAGE; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; INFANT; LIVE BIRTH; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEWBORN; PREGNANCY; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SCHOOL CHILD; SKIN BLEEDING; STROKE; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

EID: 67649371944     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.093179     Document Type: Article

References (23)

1. Bertolaccini ML, Khamashta MA, Hughes GRV. Diagnosis of antiphospholipid syndrome. Nat Clin Pract Rheumatol 2005;1:40-46
2. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-1027
3. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 1999;42:1309-1311
4. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
5. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al. Catastrophic antiphosphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003;12:530-534 (Pubitemid 36890145)
6. American Rheumatism Association glossary committee. Signs and symptoms. Dictionary of the Rheumatic Diseases 1982;1:1-80.
7. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 1993;72:113-124 (Pubitemid 23097765)
8. Tincani A, Allegri F, Sanmarco M, Cinquini M, Taglietti M, Balestrieri G, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations - a cooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001;86:575-583 (Pubitemid 32743269)
9. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185-1190
10. Derksen RHWM, de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies should receive long term anticoagulant treatment. Ann Rheum Dis 1993;52:689-692 (Pubitemid 23280441)
11. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-997
12. Muñoz-Rodríguez FJ, Font J, Cervera R, Reverter JC, Tàssies D, Espinosa G, et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 1999;29:182-190 (Pubitemid 30013282)
13. Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Lupus 2007;16:39-45. (Pubitemid 46174314)
14. Krause I, Leibovici L, Blank M, Shoenfeld Y. Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis. Lupus 2007;16:176-180 (Pubitemid 46506594)
15. Ruiz-Irastorza G, Khamashta MA, Hunt BJ, Escudero A, Cuadrado MJ, Hughes GRV. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch Intern Med 2002;162:1164-1169 (Pubitemid 34522405)
16. Erkan D, Harrison MJ, Levy R, Petersson M, Petri M, Sammaritano L, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum 2007;56:2382-2391 (Pubitemid 47173586)
17. Ruiz-Irastorza G, Egurbide MV, Pijoan JI, Garmendia M, Villar I, Martinez-Berriotxoa A, et al. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 2006;15:577-583 (Pubitemid 44661744)
18. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19:508-512
19. Piette JC, Cervera R, Levy RA, Nasonov EL, Triplett DA, Shoenfeld Y. The catastrophic antiphospholipid syndrome - Ashersons syndrome. Ann Med Intern 2003;154:195-196
20. Asherson RA, Cervera R, Piette JC, Shoenfeld Y, Espinosa G, Petri MA, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001;80:355-377 (Pubitemid 33070843)
21. Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gómez-Puerta JA, Ramos-Casals M, et al. Mortality in the catastrophic antiphospholipid syndrome. Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006;54:2568-2576
22. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. Medicine (Baltimore) 1999;78:167-175
23. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006;65:2-6.